Decision-Making Tasks for Short-Term Memory

Recruiting at 1 trial location

Overseen By Salman E Qasim, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Rutgers, The State University of New Jersey

Disqualifiers: Psychosis, Suicidal ideation, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

50 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how decisions affect short-term memory in people with epilepsy. Participants will perform tasks on a laptop to assess how making choices impacts immediate memory recall. Researchers will study brain activity during these tasks to understand the connection between decision-making and memory, using a method called value-manipulation. The trial seeks individuals with epilepsy whose seizures do not respond to standard medications and who are scheduled for specific brain monitoring procedures. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance understanding and treatment of epilepsy-related memory issues.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, since the trial involves epilepsy patients who have not responded to standard treatments, it seems likely that you may continue your current epilepsy medications.

What prior data suggests that this protocol is safe for participants with epilepsy?

Research has shown that a treatment called value-manipulation is being tested with epilepsy patients to study decision-making and memory. Specific safety information for this treatment is not yet available. The trial is in an early stage, focusing on understanding how the treatment works rather than proving its safety or effectiveness.

Value-manipulation involves using a laptop for decision-making and memory exercises. This non-invasive method does not physically affect the body and is generally considered low risk. However, since it remains experimental, all potential risks are not yet known. Participants should discuss any concerns with the research team to gain a clearer understanding of what to expect. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how value-manipulation tasks can impact decision-making and memory in individuals with epilepsy. Unlike traditional treatments that focus on medication or surgery to manage seizures, this approach uses a computer-based behavioral task to potentially enhance cognitive function. By engaging participants in decision-making exercises, the study aims to uncover new ways to improve memory and decision-making skills in epilepsy, which could lead to innovative, non-invasive therapeutic strategies.

What evidence suggests that this value-manipulation technique is effective for decision-making and memory?

Research is exploring a treatment called value-manipulation, which participants in this trial will receive, to examine how decision-making affects memory, particularly in individuals with epilepsy. Although direct proof of its benefits for memory is not yet available, studies have shown that similar treatments can significantly aid people with epilepsy. For instance, one study found that many patients experienced 60-80% fewer seizures after treatment. Another study revealed that nearly half of the patients stopped having seizures altogether, and most saw at least a 50% improvement. These findings suggest that new methods like value-manipulation might positively influence thinking skills, though its exact impact on memory remains under investigation. ^{5 6 7 8 9}

Who Is on the Research Team?

Salman E Qasim, PhD

Principal Investigator

Icahn School of Medicine at Mt. Sinai

Are You a Good Fit for This Trial?

This trial is for individuals with medication-resistant epilepsy who are already set to receive brain monitoring via intracranial EEG or neurostimulation. Participants must be able to follow the study's procedures, provide consent, and speak English or Spanish. Excluded are those with cognitive impairments, unwillingness to undergo electrode implantation, medical risks for surgery/MRI scans, pregnancy, history of psychosis, recent suicide risk, or other significant brain disorders.

Inclusion Criteria

You are proficient in either English or Spanish.

My seizures do not improve with standard medications, as confirmed by my neurologist.

I can sign and understand the consent form.

Exclusion Criteria

I am not willing or able to have an electrode implantation procedure.

I cannot have neurosurgery, general anesthesia, or an MRI due to medical reasons.

I have not had thoughts of harming myself or attempted suicide in the last six months.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Task Participation

Participants perform decision-making and memory tasks while neural activity is recorded

2 weeks

During hospital stay

Follow-up

Participants are monitored for safety and effectiveness after task participation

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Value-manipulation

Trial Overview

The study investigates how decision-making affects memory by using computational modeling and direct brain recordings during a dual-task paradigm. Patients undergoing treatment for epilepsy will have their brain activity monitored while they perform tasks designed to probe the interaction between decision-making and memory recall.

How Is the Trial Designed?

Group I: Value-manipulation Experimental Treatment 1 Intervention

Participants with epilepsy will complete a behavioral task in which they use a laptop computer to do a decision-making and memory task.

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials

471

Recruited

81,700+

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials

933

Recruited

579,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials

3,007

Recruited

2,852,000+

Published Research Related to This Trial

A study involving 89 resident-physicians and 336 non-clinicians found that both groups generally viewed the use of 'nudges'—communication techniques that guide patient choices—as ethical and appropriate in medical decision-making, especially in complex situations like choosing between chemotherapy and hospice care.

Physicians preferred nudges that supported hospice care, while non-clinicians favored nudges that promoted chemotherapy, highlighting differing perceptions of nudges between medical professionals and the general public, which could impact their application in clinical settings.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Perspectives on using decision-making nudges in physician-patient communications. Fridman, I., Hart, JL., Yadav, KN., et al.[2019]

A study of 18 pregnant women revealed that their preferences regarding pain management during childbirth changed significantly over time, indicating that immediate preferences may not reflect long-term values.

The findings suggest that measuring patient values at different times can lead to inconsistent decision-making, as preferences during active labor differed from those expressed before labor and postpartum, highlighting the need for careful consideration of timing in patient assessments.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Discount functions and the measurement of patients' values. Women's decisions during childbirth. Christensen-Szalanski, JJ.[2017]

The proposed neural network model explains human decision-making through a structured interaction between brain regions, using a proposer-predictor-actor-critic framework that adapts animal action-selection theories for human complexity.

This model suggests that decision-making involves fast, parallel computations for proposing plans, followed by slower, predictive evaluations of outcomes, with the basal ganglia acting as a reward-based critic to refine choices based on past experiences.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Neural Mechanisms of Human Decision-Making. Herd, S., Krueger, K., Nair, A., et al.[2021]

A new spiking neural network model effectively solves the complex problem of online value estimation for goal-directed decision making, achieving near-optimal performance in tasks ranging from simple choices to more complex sequential decisions.

The model's predictions align closely with behavioral data and neural responses recorded in the frontal cortices, providing a biologically realistic framework for understanding the neural mechanisms behind goal-directed actions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Goal-Directed Decision Making with Spiking Neurons. Friedrich, J., Lengyel, M.[2022]

A study involving 53 kidney transplant professionals showed that using predictive analytics for future organ offers and patient mortality significantly improved decision-making consensus and confidence among surgeons.

Visualizing patient mortality risks helped speed up decision-making processes, suggesting that incorporating patient-specific predictions could enhance the quality of transplant decisions and potentially improve patient outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

An experiment on the impact of predictive analytics on kidney offers acceptance decisions. McCulloh, I., Stewart, D., Kiernan, K., et al.[2023]

The paper highlights the importance of the hippocampus in value-based decision-making, suggesting that it plays a crucial role in processing past information to influence current choices, beyond the traditional focus on the striatum and prefrontal regions.

It proposes the successor representation (SR) as a mechanism for encoding state representations in the hippocampus, which enhances the performance of reinforcement learning agents by allowing them to process information over multiple timescales, thus improving decision-making in real-world contexts.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Accounting for multiscale processing in adaptive real-world decision-making via the hippocampus. Mehrotra, D., Dubé, L.[2023]

Neuronal activity in the orbitofrontal and anterior cingulate cortex of monkeys shows that working memory for value involves a combination of persistent and transient activity, indicating a complex mechanism for decision-making.

This hybrid coding allows for both stable and dynamic representations of value, which is essential for maintaining accurate stimulus-value associations over time.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Stable and dynamic representations of value in the prefrontal cortex. Enel, P., Wallis, JD., Rich, EL.[2021]

Monkeys were studied in a dynamic foraging environment to understand how their choices and reward histories influence their internal representation of action value, revealing insights into decision-making processes.

The research demonstrated that a simple model based on reward history could replicate the monkeys' foraging behavior, and that neurons in the parietal cortex are involved in representing the relative value of competing actions, highlighting a neural basis for value assessment.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Matching behavior and the representation of value in the parietal cortex. Sugrue, LP., Corrado, GS., Newsome, WT.[2022]

In a pilot study with 213 primary care patients, providing quantitative information about colorectal cancer screening significantly increased the likelihood of patients getting screened compared to those who did not receive this information.

While a nudge towards stool testing (FIT) increased perceived risk of colorectal cancer, it did not lead to a higher screening uptake, suggesting that simply nudging patients may not be as effective as providing clear quantitative data.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Providing Quantitative Information and a Nudge to Undergo Stool Testing in a Colorectal Cancer Screening Decision Aid: A Randomized Clinical Trial. Schwartz, PH., Perkins, SM., Schmidt, KK., et al.[2018]

Medical inpatients of all ages often misunderstand verbal descriptions of probability related to treatment risks and benefits, which raises concerns about their ability to give informed consent.

In contrast, pictorial representations of probability were much better understood by patients, indicating that using visual aids could improve patient comprehension and support better decision-making in clinical settings.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

How informed is consent? Understanding of pictorial and verbal probability information by medical inpatients. Fuller, R., Dudley, N., Blacktop, J.[2019]

Citations

1.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11869217/

Comparative Review of Seizure and Cognitive Outcomes ...

For example, a study demonstrated that resecting over 50% of the piriform cortex is associated with a 16-fold improvement in seizure-freedom ...

2.

sciencedirect.com

sciencedirect.com/science/article/pii/S1059131124001559

A meta-analytic evaluation of the effectiveness and ...

Aggregated results demonstrated that 47 % of individuals were seizure-free by the end of treatment, whilst 82 % reported a ≥ 50 % improvement in seizure ...

3.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10741568/

A Comparison of Neuropsychological Outcomes following ...

The percent reduction in seizure frequency was similar across groups with all three cohorts experiencing a 60–80% decrease post-intervention.

4.

jamanetwork.com

jamanetwork.com/journals/jamaneurology/fullarticle/2795867

Deep Learning Model for Predicting Treatment Response ...

This cohort study developed a deep learning model on a pooled cohort of 1798 adults with newly diagnosed epilepsy seen in 5 centers in 4 countries.

5.

nature.com

nature.com/articles/s41598-024-72249-7

Machine learning algorithm for predicting seizure control ...

We show that machine learning classifiers can make accurate predictions of postoperative seizure outcome using 5 min of peri-ictal scalp EEG data.

6.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11363947/

Risk Assessment Tool in Predicting the Therapeutic Outcomes ...

Identifying a patient's risk for poor outcomes after starting antiseizure medication (ASM) therapy is crucial in managing epilepsy ...

7.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10523917/

Long term epilepsy outcome dynamics revealed by natural ...

In this study we used a novel NLP algorithm to extract seizure freedom, seizure frequency, and date of most recent seizure from 55,630 free-text clinic notes ...

8.

sciencedirect.com

sciencedirect.com/science/article/pii/S1059131124002887

The value of self-reported variables in epilepsy monitoring ...

The review examined acceptability, adherence, and ability to self-report or predict seizures, along with innovative applications of self-reported data. We ...

9.

onlinelibrary.wiley.com

onlinelibrary.wiley.com/doi/full/10.1002/epd2.20288

Big data research is everyone's research—Making ...

It focuses on the general sources of Big Data in epilepsy, with overviews of how we derive clinical, electroencephalographic, imaging, ...